Drug profile · INN
tirofiban hydrochloride
AGGRASTAT
tirofiban hydrochloride (AGGRASTAT) is a integrin alpha-iib/beta-3 inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — tirofiban hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
tirofiban hydrochloride (AGGRASTAT) is a integrin alpha-iib/beta-3 inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Integrin alpha-IIb/beta-3 inhibitor
Primary target: Integrin alpha-IIb/beta-3
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tirofiban hydrochloride?
tirofiban hydrochloride (AGGRASTAT) is a integrin alpha-iib/beta-3 inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tirofiban hydrochloride?
AGGRASTAT is a marketed brand name for tirofiban hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tirofiban hydrochloride?
tirofiban hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.